Abu Dhabi’s DoH, ADIO to establish analytical laboratory with Unilabs

The parties will focus on advancing drug development, clinical trials, and screening.

The Department of Health – Abu Dhabi (DoH) and the Abu Dhabi Investment Office (ADIO) have partnered with Unilabs Pharma Solutions to develop an analytical laboratory as part of the recently launched ‘Health, Endurance, Longevity, and Medicine’ cluster.

Through a memorandum of understanding, the parties will focus on advancing drug development, clinical trials, and screening,

The analytical laboratory’s technology and operational capabilities will be deployed through a potential greenfield project.

Meanwhile, support mechanisms will be explored to maximise the initiative’s long-term economic benefits, such as high-value job creation, supply chain localisation, and increased investment in advanced healthcare infrastructure.